Connexin32 mutations cause loss of function in schwann cells and oligodendrocytes leading to PNS and CNS myelination defects

Journal of Neuroscience

Volumn 29, Issue 15, 2009, Pages 4736-4749

  Sargiannidou, Irene ^a   Vavlitou, Natalie ^a   Aristodemou, Sophia ^a   Hadjisavvas, Andreas ^a   Kyriacou, Kyriacos ^a   Scherer, Steven S ^b   Kleopa, Kleopas A ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32; GAP JUNCTION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOPLASM; DEMYELINATING DISEASE; FEMALE; GENE EXPRESSION; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHWANN CELL; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; COMPARATIVE STUDY; DOMINANT GENE; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; MYELINATED NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

ANIMALS; CENTRAL NERVOUS SYSTEM; CONNEXINS; DEMYELINATING DISEASES; FEMALE; GENES, DOMINANT; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTAGENESIS, SITE-DIRECTED; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES; SCHWANN CELLS;

EID: 65549112949     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0325-09.2009     Document Type: Article

References (62)

1. Ahn M, Lee J, Gustafsson A, Enriquez A, Lancaster E, Sul JY, Haydon PG, Paul DL, Huang Y, Abrams CK, Scherer SS (2008) Cx29 and Cx32, two con-nexins expressed by myelinating glia, do not interact and are tunctionally distinct. J Neurosci Res 86:992-1006.
2. Altevogt BM, Paul DL (2004) Four classes of intercellular channels between glial cells in the CNS. J Neurosci 24:4313-4323. (Pubitemid 38608142)
3. Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL (2002) Con- nexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 22:6458-6470. (Pubitemid 35386402)
4. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka KV, Suter U, Martini R (1997) Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin32. J Neurosci 17:4545-4551. (Pubitemid 27246912)
5. Bahr M, Andres F, Timmerman V, Nelis ME, Van Broeckhoven C, Dichgans J (1999) Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the con-nexin32 gene. J Neurol Neurosurg Psychiatry 66:202-206. (Pubitemid 29103522)
6. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH (1993) Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262:2039-2042. (Pubitemid 24041884)
7. Bruzzone R, White TW, Paul DL (1996) Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem 238:1-27. (Pubitemid 26164180)
8. Bugiani M, A1 Shahwan S, Lamantea E, Bizzi A, Bakhsh E, Moroni I, Balestrini MR, Uziel G, Zeviani M (2006) GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology 67:273-279. (Pubitemid 44305412)
9. Das Sarma J, Meyer RA, Wang F, Abraham V, Lo CW, Koval M (2001) Multimeric connexin interactions prior to the trans-Golgi network. J Cell Sci 114:4013-4024. (Pubitemid 33115022)
10. Dermietzel R, Traub O, Hwang TK, Beyer E, Bennett MV, Spray DC, Willecke K (1989) Differential expression of three gap junction proteins in developing and mature brain tissues. Proc Natl Acad Sci U S A 86:10148-10152. (Pubitemid 20030796)
11. Deschênes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH (1997) Altered trafficking of mutant connexin 32. J Neurosci 17:9077-9084. (Pubitemid 27498435)
12. Forge A, Marziano NK, Casalotti SO, Becker DL, Jagger D (2003) The inner ear contains heteromeric channels composed of cx26 and cx30 and deafness-related mutations in cx26 have a dominant negative effect on cx30. Cell Commun Adhes 10:341-346. (Pubitemid 38081395)
13. Gravel M, Di Polo A, Valera PB, Braun PE (1998) Four-kilobase sequence of the mouse CNP gene directs spatial and temporal expression of lacZ in transgenic mice. J Neurosci Res 53:393-404. (Pubitemid 28363201)
14. Hahn AF, Ainsworth PJ, Naus CCG, Mao J, Bolton CF (2000) Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve 23:S39-S48.
15. Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Na-kashima K, Kira J, Kaji R, Oka N, Sobue G, Study Group for Hereditary Neuropathy in Japan (2003) Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): A clinicopathological study of 205 Japanese patients. Brain 126:134-151. (Pubitemid 36068564)
16. Huang Y, Sirkowski EE, Stickney JT, Scherer SS (2005) Prenylation-defective human connexin32 mutants are normally localized and function equivalently to wild-type connexin32 in myelinating Schwann cells. J Neurosci 25:7111-7120. (Pubitemid 41113927)
17. Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS (2006) The effects of a dominant connexin32 mutant in myelinating Schwann cells. Mol Cell Neurosci 32:283-298. (Pubitemid 44026520)
18. Kamasawa N, Sik A, Morita M, Yasumura T, Davidson KG, Nagy JI, Rash JE (2005) Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: Implications for ionic homeostasis and potassium siphoning. Neuroscience 136:65-86. (Pubitemid 41483836)
19. Kleopa KA, Scherer SS (2006) Molecular genetics of X-linked Charcot-Marie-Tooth disease. Neuromolecular Med 8:107-122. (Pubitemid 43918169)
20. Kleopa KA, Yum SW, Scherer SS (2002) Cellular mechanisms of con-nexin32 mutations associated with CNS manifestations. J Neurosci Res 68:522-534. (Pubitemid 34575618)
21. Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS (2004) Unique distribution of gap junction proteins connexin29, connexin32, and con-nexin47 in oligodendrocytes. Glia 47:346-357. (Pubitemid 39295418)
22. Kleopa KA, Zamba-Papanicolaou E, Alevra X, Nicolaou P, Georgiou DM, Hadjisavvas A, Kyriakides T, Christodoulou K (2006) Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X. Neurology 66:396-402.
23. Li X, Ionescu AV, Lynn BD, Lu S, Kamasawa N, Morita M, Davidson KG, Yasumura T, Rash JE, Nagy JI (2004) Connexin47, connexin29 and con-nexin32 co-expression in oligodendrocytes and Cx47 association with zonula occludens-1 (ZO-1) in mouse brain. Neuroscience 126:611-630. (Pubitemid 38759255)
24. Marziano NK, Casalotti SO, Portelli AE, Becker DL, Forge A (2003) Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30. Hum Mol Genet 12:805-812. (Pubitemid 36504023)
25. Maza J, Das Sarma J, Koval M (2005) Defining a minimal motif required to prevent connexin oligomerization in the endoplasmic reticulum. J Biol Chem 280:21115-21121. (Pubitemid 40805671)
26. Meier C, Dermietzel R, Davidson KG, Yasumura T, Rash JE (2004) Connexin32-containing gap junctions in Schwann cells at the internodal zone of partial myelin compaction and in Schmidt-Lanterman incisures. J Neurosci 24:3186-3198. (Pubitemid 38451885)
27. Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL (2003) Connexins are critical for normal myelination in the CNS. J Neurosci 23:5963-5973. (Pubitemid 36807876)
28. Menichella DM, Majdan M, Awatramani R, Goodenough DA, Sirkowski E, Scherer SS, Paul DL (2006) Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J Neurosci 26:10984-10991.
29. Musil LS, Goodenough DA (1993) Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occurs after exit from the ER. Cell 74:1065-1077. (Pubitemid 23289463)
30. Nadarajah B, Jones AM, Evans WH, Parnavelas JG (1997) Differential expression of connexins during neocortical development and neuronal circuit formation. J Neurosci 17:3096-3111. (Pubitemid 27175822)
31. Nagy JI, Ionescu AV, Lynn BD, Rash JE (2003) Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice. Glia 44:205-218. (Pubitemid 37484472)
32. Nakagawa M, Takashima H, Umehara F, Arimura K, Miyashita F, Takenou-chi N, Matsuyama W, Osame M (2001) Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci 185:31-37. (Pubitemid 32215499)
33. Nelles E, Bützler C, Jung D, Temme A, Gabriel HD, Dahl U, Traub O, Stümpel F, Jungermann K, Zielasek J, Toyka KV, Dermietzel R, Willecke K (1996) Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci U S A 93:9565-9570. (Pubitemid 26296648)
34. Nicholson G, Corbett A (1996) Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brain auditory evoked responses. J Neurol Neurosurg Psychiatry 61:43-46. (Pubitemid 26232026)
35. Nicholson GA, Yeung L, Corbett A (1998) Efficient neurophysiological selection of X-linked Charcot-Marie-Tooth families. Neurology 51:1412-1416. (Pubitemid 28520568)
36. Odermatt B, Wellershaus K, Wallraff A, Seifert G, Degen J, Euwens C, Fuss B, Büssow H, Schilling K, Steinhäuser C, Willecke K (2003) Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci 23:4549-4559. (Pubitemid 36706185)
37. Oh S, Ri Y, Bennett MV, Trexler EB, Verselis VK, Bargiello TA (1997) Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron 19:927-938. (Pubitemid 27471396)
38. Omori Y, Mesnil M, Yamasaki H (1996) Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: Functional defects and dominant negative effects. Mol Biol Cell 7:907-916. (Pubitemid 26181726)
39. Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS (2007a) Loss-of-function connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci 34:629-641. (Pubitemid 46486711)
40. Orthmann-Murphy JL, Freidin M, Fischer E, Scherer SS, Abrams CK (2007b) Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J Neurosci 27:13949-13957. (Pubitemid 46495259)
41. Panas M, Kalfakis N, Karadimas C, Vassilopoulos D (2001) Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 gene. Neurology 57:1906-1908. (Pubitemid 33096707)
42. Parnavelas JG, Luder R, Pollard SG, Sullivan K, Lieberman AR (1983) A qualitative and quantitative ultra structural study of glial cells in the developing visual cortex of the rat. Philos Trans R Soc Lond B Biol Sci 301:55-84.
43. Paulson HL, Garbern JY, Hoban TF, Krajewski KM, Lewis RA, Fischbeck KH, Grossman RI, Lenkinski R, Kamholz JA, Shy ME (2002) Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol 52:429-434.
44. Plantard L, Huber M, Macari F, Meda P, Hohl D (2003) Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis. Hum Mol Genet 12:3287-3294. (Pubitemid 37541074)
45. Rash JE, Yasumura T, Dudek FE, Nagy JI (2001) Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J Neurosci 21:1983-2000. (Pubitemid 32221382)
46. Sargiannidou I, Ahn M, Enriquez AD, Peinado A, Reynolds R, Abrams C, Scherer SS, Kleopa KA (2008) Human oligodendrocytes express Cx 31.3: Function and interactions with Cx32 mutants. Neurobiol Dis 30:221-233.
47. Scherer SS, Deschenes SM, Xu YT, Grinspan JB, Fischbeck KH, Paul DL (1995) Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 15:8281-8294. (Pubitemid 26009680)
48. Scherer SS, Xu YT, Nelles E, Fischbeck K, Willecke K, Bone LJ (1998) Connexin32-null mice develop a demyelinating peripheral neuropathy. Glia 24:8-20. (Pubitemid 28370208)
49. Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ (2005) Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J Neurosci 25:1550-1559. (Pubitemid 40250731)
50. Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, Ain-sworth PJ, Lewis RA, Scherer SS, Hahn AF (2007) CMT1X phenotypes represent loss of GJB1 gene function. Neurology 68:849-855. (Pubitemid 46568537)
51. Silvius JR (2002) Mechanisms of Ras protein targeting in mammalian cells. J Membr Biol 190:83-92. (Pubitemid 36930423)
52. Sutor B, Schmolke C, Teubner B, Schirmer C, Willecke K (2000) Myelination defects and neuronal hyperexcitability in the neocortex of connexin 32-deficient mice. Cereb Cortex 10:684-697. (Pubitemid 30460505)
53. Tang Y, Nyengaard JR (1997) A stereological method for estimating the total length and size of myelin fibers in human brain white matter. J Neurosci Methods 73:193-200. (Pubitemid 27244816)
54. Taylor RA, Simon EM, Marks HG, Scherer SS (2003) The CNS phenotype of X-linked Charcot-Marie-Tooth disease: More than a peripheral problem. Neurology 61:1475-1478. (Pubitemid 37505564)
55. Thomas T, Telford D, Laird DW (2004) Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations. J Biol Chem 279:19157-19168. (Pubitemid 38623347)
56. Uhlenberg B, Schuelke M, Rüschendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg-Didinger G, Aksu F, Topaloηlu H, Nürnberg P, Hübner C, Weschke B, Gärtner J (2004) Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet 75:251-260. (Pubitemid 38943868)
57. VanSlyke JK, Deschenes SM, Musil LS (2000) Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins. Mol Biol Cell 11:1933-1946. (Pubitemid 30408055)
58. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Güldenagel M, Deutsch U, Söh; G (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383:725-737. (Pubitemid 34649891)
59. Wright LP, Philips MR (2006) Thematic review series: Lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res 47:883-891.
60. Yuan X, Chittajallu R, Belachew S, Anderson S, McBain CJ, Gallo V (2002) Expression of the green fluorescent protein in the oligodendrocyte lineage: A transgenic mouse for developmental and physiological studies. J Neurosci Res 70:529-545. (Pubitemid 35253523)
61. Yum SW, Kleopa KA, Shumas S, Scherer SS (2002) Diverse trafficking abnormalities of Connexin32 mutants causing CMTX. Neurobiol Dis 11:43-52. (Pubitemid 35435673)
62. Yum SW, Zhang J, Valiunas V, Kanaporis G, Brink PR, White TW, Scherer SS (2007) Human connexin26 and connexin30 form functional heteromeric and heterotypic channels. Am J Physiol Cell Physiol 293:C1032-C1048. (Pubitemid 47437388)